Portal de Periódicos da CAPES

Patient Identification of the Symptomatic Impact of Charcot–Marie–Tooth Disease Type 1A

2013; Lippincott Williams & Wilkins; Volume: 15; Issue: 1 Linguagem: Inglês

10.1097/cnd.0b013e31829e22e3

1537-1611

Nicholas Johnson, Chad Heatwole, Michele Ferguson, Janet E. Sowden, Shanie Jeanat, David N. Herrmann,

Botulinum Toxin and Related Neurological Disorders

Objective: The burden of Charcot–Marie–Tooth type 1A (CMT1A), the most common inherited peripheral neuropathy, including impact on patient quality of life (QOL) is not well understood. This study aims to qualitatively describe the range of symptoms associated with CMT1A and impact on QOL. Methods: We performed qualitative interviews with 16 adult CMT1A patients. Each interview was analyzed using a qualitative framework technique to identify and index symptoms by theme. Results: Sixteen patients provided 656 quotes. One hundred forty-five symptoms of importance were identified representing 20 symptomatic themes. Symptoms associated with difficulty with mobility and ambulation, specific activity impairment, and emotional distress were the most frequently mentioned. Conclusions: Multiple symptoms contribute to CMT1A disease burden, some previously underrecognized. Improved recognition of underrecognized symptoms will optimize patient care and QOL.